Priapism
8
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
75%
3 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Investigation of the Protective Effect of Alpha Lipoic Acid on Ischemic Reperfusion Damage in Ischemic Priapism in Rats
The Sequestration of Holistic Stress Management Techniques for Adults
A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism
ManAgement of pRiapiSm and Its Impact on Outcomes
Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence
Sildenafil for Treatment of Priapism in Men With Sickle Cell Anemia
Androgen Regulation of Priapism in Sickle Cell Disease
Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia